HHS, HCFA REJECT "SPECIAL" REIMBURSEMENT FOR GENETECH's ACTIVASE; HCFA OPPOSES PRECEDENT OF BLANK CHECK SUBSIDY FOR SINGLE-SOURCE TREATMENT

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".